Northpond Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
24
- Investments
-
110
- Portfolio
-
56
- Exits
-
13
Northpond Ventures General Information
Description
Founded in 2018, Northpond Ventures is a venture capital firm based in Cambridge, Massachusetts. The firm prefers to invest in companies operating in the diagnostics, life science, digital health, technology, synthetic biology, and therapeutics sectors.
Contact Information
Website
www.npv.vc
Year Founded
2018
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
- 4 Brattle Street
- Floor 3
- Cambridge, MA 02138
- United States
+1 (857) 000-0000
Northpond Ventures Investments (110)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Telesis Bio | 31-May-2023 | PIPE | 0000 | Discovery Tools (Healthcare) | Generating Revenue | 000000 0000000 |
| 000000 | 28-Feb-2023 | 00000 00000 | 0000 | Diagnostic Equipment | Generating Revenue | 0000 0000000000 00.0 |
| 0000 | 08-Feb-2023 | 00000 00000 | 0000 | Enterprise Systems (Healthcare) | Generating Revenue | |
| 000000000 (0000000 | 06-Feb-2023 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000 0000000000 00.0 |
| 000000 00000000000 | 24-Jan-2023 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | 000000 00000 00.0 |
| 0000000 00 | 17-Jan-2023 | 000000000000 | 00000 | Other Healthcare Technology Systems | Generating Revenue | |
| 00000 | 07-Dec-2022 | 00000 00000 | 0000 | Cultivation | Generating Revenue | |
| 0000 000 | 21-Nov-2022 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 00000 000000 00.0 |
| EnPlusOne Biosciences | 30-Sep-2022 | Seed Round | 000.00 | Biotechnology | Startup | 000000 000 00.0 |
| Elephas | 06-Sep-2022 | Early Stage VC | 000.00 | Diagnostic Equipment | Clinical Trials - General | 000000 0000000 |
Northpond Ventures Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| StrideBio | 03-Apr-2023 | Merger/Acquisition | 00.00 |
| 0000000 000 | 21-Feb-2023 | 000000000000000000 | 000.00 |
| 0000 0000 | 27-Jan-2023 | 000000000000000000 | |
| 00000000 000000000 | 04-May-2022 | 0000000000 | |
| 00000000 000000 00 | 18-Feb-2022 | 000000000000000000 | 00000 |
| 00000 00000 | 07-Jan-2022 | 000 | 0000 |
| 0000000 000000 | 02-Nov-2021 | 000000000000000000 | 00000 |
| 000000000 | 08-Oct-2021 | 000 | 00000 |
| DICE Therapeutics | 15-Sep-2021 | IPO | 00000 |
| Candel Therapeutics | 27-Jul-2021 | IPO | 0000 |
Northpond Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Northpond Ventures Team (37)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Michael Rubin MD | Co-Founder & Chief Executive Officer | 00 | 0 | 0 | Bethesda, MD |
| Patrick Smerkers | Chief Financial Officer & Partner | 0 | Bethesda, MD | ||
| Adam Wieschhaus Ph.D | Managing Director | 0 | 0 | Bethesda, MD | |
| Daniel Janse Ph.D | Managing Director | 0 | 0 | 0 | Bethesda, MD |
| Andrea Jackson | Partner | 00 | 00 | Bethesda, MD |
Northpond Ventures Co-Investors (391)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Sands Capital | 8 | 0 | 0 |
|
|
| Alexandria Venture Investments | 0 | 0 | 0 |
|
|
| ARCH Venture Partners | 0 | 0 | 0 |
|
|
| Section 32 | 0 | 0 | 0 |
|
|
| Tao Capital Partners | 0 | 0 | 0 |
|
|